Tg(Col1a1-cre)1Kry/0
Vdrtm2Ska/Vdrtm2Ska
involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj * FVB/N
|
abnormal osteoclast differentiation |
J:196471
|
|
decreased bone resorption |
J:196471
|
|
decreased osteoclast cell number |
J:196471
|
|
normal
homeostasis/metabolism phenotype |
J:196471
|
|
increased bone mass |
J:196471
|
|
increased bone mineral density |
J:196471
|
|
increased trabecular bone volume |
J:196471
|
|
normal
skeleton phenotype |
J:196471
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
involves: 129 * BALB/c * C57BL/6 * Swiss
|
abnormal vitamin D level |
J:72578
|
|
decreased body weight |
J:72578
|
|
decreased bone mineral density |
J:72578
|
|
decreased circulating calcium level |
J:72578
|
|
decreased intestinal calcium absorption |
J:72578
|
|
increased circulating parathyroid hormone level |
J:72578
|
|
rickets |
J:72578
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
involves: 129S1/Sv * 129X1/SvJ
|
abnormal bone mineralization |
J:111515
|
|
abnormal urine homeostasis |
J:111515
|
|
abnormal vitamin D level |
J:111515
|
|
decreased bone mineral density |
J:111515
|
|
decreased circulating calcium level |
J:111515
|
|
decreased uterus weight |
J:111515
|
|
rickets |
J:111515
|
Vdrtm1.1Sgcg/Vdrtm1.2Sgcg
Myl2tm1(cre)Krc/Myl2+
involves: 129 * C57BL/6 * CBA * SJL
|
abnormal heart ventricle morphology |
J:189471
|
|
cardiac hypertrophy |
J:189471
|
|
normal
cardiovascular system phenotype |
J:189471
|
|
decreased mean systemic arterial blood pressure |
J:189471
|
|
decreased systemic arterial diastolic blood pressure |
J:189471
|
|
normal
endocrine/exocrine gland phenotype |
J:189471
|
|
normal
homeostasis/metabolism phenotype |
J:189471
|
|
increased circulating atrial natriuretic factor |
J:189471
|
|
increased heart left ventricle weight |
J:189471
|
|
increased myocardial fiber size |
J:189471
|
|
thick interventricular septum |
J:189471
|
|
thick ventricular wall |
J:189471
|
Vdrtm1.2Sgcg/Vdrtm1.2Sgcg
involves: 129 * C57BL/6 * CBA * SJL
|
alopecia |
J:189471
|
|
decreased body weight |
J:189471
|
|
decreased circulating calcium level |
J:189471
|
|
increased activity of parathyroid |
J:189471
|
|
increased circulating atrial natriuretic factor |
J:189471
|
|
increased heart left ventricle weight |
J:189471
|
Vdrtm1Gcm/Vdrtm1Gcm
Tg(Col2a1-cre)1Bhr/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
|
abnormal mineral homeostasis |
J:117377
|
|
abnormal trabecular bone morphology |
J:117377
|
|
abnormal vitamin D level |
J:117377
|
|
decreased angiogenesis |
J:117377
|
|
decreased osteoclast cell number |
J:117377
|
|
delayed endochondral bone ossification |
J:117377
|
|
increased circulating phosphate level |
J:117377
|
Vdrtm1Mbd/Vdr+
involves: 129S4/SvJae
|
increased bone mass |
J:196471
|
|
increased bone mineral density |
J:196471
|
|
increased trabecular bone volume |
J:196471
|
Vdrtm1Mbd/Vdr+
involves: 129S4/SvJae * C57BL/6
|
normal
cardiovascular system phenotype |
J:120353
|
|
increased heart weight |
J:120353
|
Vdrtm1Mbd/Vdrtm1Mbd
involves: 129S4/SvJae
|
abnormal bone mineralization |
J:42815
|
|
abnormal tibia morphology |
J:42815
|
|
alopecia |
J:42815
|
|
decreased body weight |
J:42815
|
|
decreased circulating calcium level |
J:42815,
J:78067
|
|
dermal cyst |
J:42815
|
|
dilated hair follicle |
J:42815
|
|
disorganized long bone epiphyseal plate |
J:42815
|
|
enlarged parathyroid gland |
J:42815
|
|
hypertension |
J:78067
|
|
increased circulating angiotensin II level |
J:78067
|
|
increased circulating angiotensinogen level |
J:78067
|
|
increased circulating parathyroid hormone level |
J:42815,
J:63291,
J:78067
|
|
increased circulating renin level |
J:78067
|
|
increased fluid intake |
J:78067
|
|
increased heart weight |
J:78067
|
|
increased renin activity |
J:78067
|
|
increased systemic arterial diastolic blood pressure |
J:78067
|
|
increased systemic arterial systolic blood pressure |
J:78067
|
|
increased urine potassium level |
J:78067
|
|
increased urine sodium level |
J:78067
|
|
increased width of hypertrophic chondrocyte zone |
J:42815
|
|
polyuria |
J:78067
|
|
postnatal growth retardation |
J:42815
|
|
rickets |
J:42815
|
|
short femur |
J:42815
|
|
short tibia |
J:42815
|
Vdrtm1Mbd/Vdrtm1Mbd
involves: 129S4/SvJae * C57BL/6
|
abnormal enzyme/coenzyme activity |
J:120340
|
|
abnormal interleukin level |
J:107077
|
|
abnormal intestinal epithelium morphology |
J:130511
|
|
abnormal intestinal mucosa morphology |
J:130511
|
|
abnormal large intestine crypts of Lieberkuhn morphology |
J:130511
|
|
abnormal myocardial fiber physiology |
J:131143
|
|
abnormal renin activity |
J:120353
|
|
abnormal tumor necrosis factor level |
J:107077
|
|
cardiac fibrosis |
J:120340
|
|
cardiac hypertrophy |
J:120340
|
|
normal
cardiovascular system phenotype |
J:120353
|
|
decreased systemic arterial systolic blood pressure |
J:120353
|
|
normal
immune system phenotype |
J:107077
|
|
increased heart weight |
J:120340,
J:120353
|
|
increased susceptibility to induced colitis |
J:130511
|
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:130511
|
|
increased thymus weight |
J:107077
|
|
intestinal inflammation |
J:107077
|
|
intestinal ulcer |
J:130511
|
|
thymus hyperplasia |
J:107077
|
|
weight loss |
J:130511
|
Vdrtm1Mbd/Vdrtm1Mbd
involves: 129S4/SvJae * C57BL/6J
|
abnormal chondrocyte morphology |
J:99866
|
|
abnormal mineral homeostasis |
J:99866
|
|
decreased circulating phosphate level |
J:99866
|
|
increased width of hypertrophic chondrocyte zone |
J:99866
|
|
rickets |
J:99866
|
Vdrtm1Rge/Vdrtm1Rge
B6.129-Vdrtm1Rge
|
decreased bone mineral density |
J:121006
|
|
decreased circulating phosphate level |
J:121006
|
|
epidermal cyst |
J:121006
|
|
increased circulating alkaline phosphatase level |
J:121006
|
|
increased circulating parathyroid hormone level |
J:121006
|
Vdrtm1Rge/Vdrtm1Rge
involves: 129S1/Sv * 129X1/SvJ
|
abnormal response to vitamins |
J:77748
|
|
abnormal vitamin D level |
J:77748
|
|
alopecia |
J:77748
|
|
decreased circulating calcium level |
J:77748
|
|
increased activity of parathyroid |
J:77748
|
|
increased circulating parathyroid hormone level |
J:77748
|
|
increased urine calcium level |
J:77748
|
|
rickets |
J:77748
|
|
slow postnatal weight gain |
J:77748
|
Vdrtm1Rge/Vdrtm1Rge
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal macrophage physiology |
J:134827
|
|
abnormal nitric oxide homeostasis |
J:134827
|
|
decreased susceptibility to parasitic infection |
J:134827
|
Vdrtm1Ska/Vdrtm1Ska
involves: 129 * C57BL/6NCrlj * CBA/JNCrlj
|
abnormal locomotor activation |
J:95324
|
|
abnormal response to new environment |
J:95324
|
|
abnormal startle reflex |
J:95324
|
|
alopecia |
J:95324
|
|
decreased body size |
J:95324
|
|
decreased locomotor activity |
J:95324
|
|
decreased prepulse inhibition |
J:95324
|
|
decreased vertical activity |
J:95324
|
|
impaired coordination |
J:95324
|
|
short stride length |
J:95324
|
Vdrtm1Ska/Vdrtm1Ska
involves: C57BL/6NCrlj * CBA/JNCrlj
|
abnormal blood homeostasis |
J:112519
|
|
abnormal bone mineralization |
J:112519
|
|
abnormal bone ossification |
J:42054
|
|
abnormal bone structure |
J:42054
|
|
abnormal coat/ hair morphology |
J:110729
|
|
abnormal colon morphology |
J:71459
|
|
abnormal epidermis stratum granulosum morphology |
J:110729
|
|
abnormal estrous cycle |
J:83237
|
|
abnormal fat-soluble vitamin level |
J:71459,
J:112519
|
|
abnormal female reproductive system morphology |
J:42054
|
|
abnormal fertility/fecundity |
J:42054
|
|
abnormal fibula morphology |
J:42054
|
|
abnormal gametogenesis |
J:83237
|
|
abnormal large intestine crypts of Lieberkuhn morphology |
J:71459
|
|
abnormal limb bone morphology |
J:42054
|
|
abnormal long bone hypertrophic chondrocyte zone |
J:42054
|
|
abnormal long bone metaphysis morphology |
J:42054
|
|
abnormal macrophage chemotaxis |
J:112519
|
|
abnormal male reproductive system morphology |
J:83237
|
|
abnormal skin development |
J:110729
|
|
abnormal spermatogenesis |
J:83237
|
|
abnormal tibia morphology |
J:42054
|
|
abnormal trabecular bone morphology |
J:42054
|
|
abnormal vitamin D level |
J:42054
|
|
absent mature ovarian follicles |
J:42054
|
|
alopecia |
J:42054,
J:67149,
J:110729
|
|
asthenozoospermia |
J:83237
|
|
decreased body weight |
J:42054,
J:72578
|
|
decreased bone mineral density |
J:42054,
J:72578
|
|
decreased circulating calcium level |
J:42054,
J:69822,
J:71459,
J:72578,
J:83237,
J:112519
|
|
decreased circulating phosphate level |
J:42054
|
|
decreased compact bone thickness |
J:42054
|
|
decreased hair follicle cell proliferation |
J:110729
|
|
decreased intestinal calcium absorption |
J:72578
|
|
decreased splenocyte proliferation |
J:112519
|
|
decreased susceptibility to autoimmune diabetes |
J:112519
|
|
dermal cyst |
J:110729
|
|
dermatitis |
J:111828
|
|
dilated hair follicle |
J:110729
|
|
dilated seminiferous tubule |
J:83237
|
|
female infertility |
J:42054,
J:69822
|
|
flat face |
J:42054
|
|
increased circulating alkaline phosphatase level |
J:42054
|
|
increased circulating follicle stimulating hormone level |
J:83237
|
|
increased circulating luteinizing hormone level |
J:83237
|
|
increased long bone epiphyseal plate size |
J:42054
|
|
increased osteoblast cell number |
J:42054
|
|
increased testis weight |
J:83237
|
|
normal
integument phenotype |
J:111828
|
|
male infertility |
J:42054,
J:69822
|
|
oligozoospermia |
J:83237
|
|
postnatal growth retardation |
J:42054,
J:110729
|
|
premature death |
J:42054,
J:69822
|
|
reduced female fertility |
J:69822
|
|
reduced male fertility |
J:69822
|
|
rickets |
J:72578,
J:110729
|
|
short snout |
J:42054
|
|
sparse vibrissae |
J:42054
|
|
uterus hypoplasia |
J:42054
|
Vdrtm1Ska/Vdrtm1Ska
NOD.Cg-Vdrtm1Ska/CmatJ
|
abnormal chemokine secretion |
J:127787
|
|
abnormal dendritic cell differentiation |
J:127787
|
|
abnormal glucose tolerance |
J:127787
|
|
abnormal interleukin-1 secretion |
J:127787
|
|
abnormal T cell number |
J:127787
|
|
alopecia |
J:127787
|
|
decreased bone mineral density |
J:127787
|
|
decreased circulating calcium level |
J:127787
|
|
decreased interleukin-6 secretion |
J:127787
|
|
decreased regulatory T cell number |
J:127787
|
|
increased long bone epiphyseal plate size |
J:127787
|
|
increased susceptibility to autoimmune diabetes |
J:127787
|
|
postnatal growth retardation |
J:127787
|
Vdrtm1Tyam/Vdrtm1Tyam
involves: C57BL/6 * CBA
|
abnormal femur morphology |
J:101456
|
|
abnormal vitamin D level |
J:101456
|
|
decreased body weight |
J:101456
|
|
decreased bone mineral density of femur |
J:101456
|
|
decreased circulating calcium level |
J:101456
|
|
decreased circulating phosphate level |
J:101456
|
|
increased circulating parathyroid hormone level |
J:101456
|
|
increased width of hypertrophic chondrocyte zone |
J:101456
|
|
postnatal growth retardation |
J:101456
|
|
short femur |
J:101456
|
Vdrtm2.1Ska/Vdr+
involves: C57BL/6 * CBA/JNCrlj * SJL
|
increased bone mass |
J:196471
|
|
increased bone mineral density |
J:196471
|
|
increased trabecular bone volume |
J:196471
|
Vdrtm2.1Ska/Vdrtm2.1Ska
involves: C57BL/6 * CBA/JNCrlj * SJL
|
abnormal bone ossification |
J:196471
|
|
abnormal vitamin D level |
J:196471
|
|
alopecia |
J:196471
|
|
decreased circulating calcium level |
J:196471
|
|
decreased circulating phosphate level |
J:196471
|
|
disorganized long bone epiphyseal plate |
J:196471
|
|
increased activity of parathyroid |
J:196471
|
|
increased osteoid volume |
J:196471
|
|
postnatal growth retardation |
J:196471
|
|
premature death |
J:196471
|
|
weight loss |
J:196471
|
Vdrtm2Ska/Vdrtm2Ska
involves: C57BL/6NCrlj * CBA/JNCrlj
|
ear inflammation |
J:111828
|
|
mixed cellular infiltration to dermis |
J:111828
|
Vdrtm2Ska/Vdrtm2Ska
Tg(KRT14-cre)1Ipc/0
involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL
|
normal
integument phenotype |
J:111828
|
Excel File
Analysis Tools